Delivery systems for transcatheter therapies of congenital heart disease
Authors:
- 13 September 2024
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Medical Devices
- Vol. 21 (10) , 903-913
Abstract
IntroductionDelivery systems are crucially important for the implantation of medical devices in patients with congenital heart disease. However, very little data is available comparing the advantages and disadvantages of the various delivery systems.Areas coveredThis article describes the delivery systems and methods used for delivery of atrial septal occluder devices, ventricular septal occluder devices, devices to occlude patent arterial ducts, and transcatheter pulmonary valves. Delivery systems are compared relating to prepping and loading, positioning of the delivery sheath/catheter, deployment, ability to recapture and reposition, as well as device release.Expert opinionFor most ASD/VSD/PDA occluder devices, the basic delivery mechanism has changed very little over the preceding 20 years. Future modifications may focus on meaningful modifications to the cable systems that reduce stiffness and improve angulation at the connection to the device. Over the next 5-10 years, it is expected to see significant changes to delivery systems used for transcatheter pulmonary valve implantation, that result in improvements in the ability to recapture and reposition self-expandable transcatheter valves during the deployment process, combined with kink resistant sheaths that facilitate easy tracking across often complex right ventricular outflow tracts.Keywords
This publication has 44 references indexed in Scilit:
- Five‐year follow‐up after percutaneous pulmonary valve implantation using the Venus P‐valve system for patients with pulmonary regurgitation and an enlarged native right ventricular outflow tractCatheterization and Cardiovascular Interventions, 2023
- Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≥700 gramsCatheterization and Cardiovascular Interventions, 2020
- Early clinical experience with the straight design of Venus P‐valve™ in dysfunctional right ventricular outflow tractsCatheterization and Cardiovascular Interventions, 2020
- Percutaneous closure of restrictive‐type perimembranous ventricular septal defect using the new KONAR multifunctional occluder: Midterm outcomes of the first middle‐eastern experienceCatheterization and Cardiovascular Interventions, 2019
- First human implant of the Alterra Adaptive PrestentTM: A new self‐expanding device designed to remodel the right ventricular outflow tractCatheterization and Cardiovascular Interventions, 2018
- Initial clinical experience with the GORE® CARDIOFORM ASD occluder for transcatheter atrial septal defect closureCatheterization and Cardiovascular Interventions, 2017
- Closure of very large PDA with pulmonary hypertension: Initial clinical case‐series with the new Occlutech® PDA occluderCatheterization and Cardiovascular Interventions, 2016
- The new Occlutech® PDA occluder: Initial human experienceCatheterization and Cardiovascular Interventions, 2015
- A new device to close secundum atrial septal defects: First clinical use to close multiple defects in a childCatheterization and Cardiovascular Interventions, 2008
- Transcatheter closure of patent ductus arteriosus with Nit-Occlud coilsCatheterization and Cardiovascular Interventions, 2005